Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease

被引:248
作者
Scanlan, Pauline D.
Shanahan, Fergus
O'Mahony, Caitlin
Marchesi, Julian R. [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland
[2] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland
关键词
D O I
10.1128/JCM.00312-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Gut microbiota shows host-specific diversity and temporal stability and significantly contributes to maintenance of a healthy gut. However, in inflammatory bowel disease, this microbiota has been implicated as a contributory factor to the illness. This study compared bacterial dynamics in Crohn's disease patients to those in a control group using a culture-independent method to assess the temporal stability, relative diversity, and similarity of the dominant fecal microbiota, Clostridium spp., Bacteroides spp., Bifidobacterium spp., and lactic acid bacteria spp. (LAB) for all individuals. Fecal samples were collected over several time points from individuals with Crohn's disease who were in remission (n = 11), from Crohn's disease patients who relapsed into an active Crohn's disease state (n = 5), and from a control group (n = 18). Denaturing gradient gel electrophoresis profiles were generated for the different microbial groups by specifically targeting different regions of the 16S rRNA gene and were compared on the basis of similarity and diversity. The temporal stability of dominant species for all Crohn's disease patients was significantly lower (P < 0.005) than that for the control group. Analysis of group-specific profiles for Bifidobacterium spp. found that they were similar in all samples, while the diversity of the LAB varied significantly between the groups, but temporal stability was not significantly altered. We observed significant changes in two functionally important mutualistic groups of bacteria, viz., Clostridium and Bacteroides spp., which may have implications for the host's gut health, since some genera are involved in production of short-chain fatty acid, e.g., butyrate.
引用
收藏
页码:3980 / 3988
页数:9
相关论文
共 68 条
[41]   Probiotics: An emerging therapy [J].
O'Sullivan, GC ;
Kelly, P ;
O'Halloran, S ;
Collins, C ;
Collins, JK ;
Dunne, C ;
Shanahan, F .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (01) :3-10
[42]   A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease [J].
Ogura, Y ;
Bonen, DK ;
Inohara, N ;
Nicolae, DL ;
Chen, FF ;
Ramos, R ;
Britton, H ;
Moran, T ;
Karaliuskas, R ;
Duerr, RH ;
Achkar, JP ;
Brant, SR ;
Bayless, TM ;
Kirschner, BS ;
Hanauer, SB ;
Nuñez, G ;
Cho, JH .
NATURE, 2001, 411 (6837) :603-606
[43]  
Orholm M, 2000, SCAND J GASTROENTERO, V35, P1075
[44]   Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease [J].
Ott, SJ ;
Musfeldt, M ;
Wenderoth, DF ;
Hampe, J ;
Brant, O ;
Fölsch, UR ;
Timmins, KN ;
Schreiber, S .
GUT, 2004, 53 (05) :685-693
[45]   Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease [J].
Prindiville, T ;
Cantrell, M ;
Wilson, KH .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) :824-833
[46]   The microbiology of butyrate formation in the human colon [J].
Pryde, SE ;
Duncan, SH ;
Hold, GL ;
Stewart, CS ;
Flint, HJ .
FEMS MICROBIOLOGY LETTERS, 2002, 217 (02) :133-139
[47]  
Sambrook J., 2000, MOL CLONING LAB MANU
[48]   Intestinal microflora in human and experimental inflammatory bowel disease [J].
Sartor, RB .
CURRENT OPINION IN GASTROENTEROLOGY, 2001, 17 (04) :324-330
[49]   MICROBIAL ECOLOGY OF GASTROINTESTINAL-TRACT [J].
SAVAGE, DC .
ANNUAL REVIEW OF MICROBIOLOGY, 1977, 31 :107-133
[50]   The butyrate story: old wine in new bottles? [J].
Scheppach, W ;
Weiler, F .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (05) :563-567